Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endosense SA

Division of Abbott Laboratories Inc.
www.endosense.com

Latest From Endosense SA

AF Ablation Procedures Driving CRM Market Expansion

Cardiac rhythm management device sales in the US are projected to grow at a compound annual rate of 2.9%, increasing to an estimated $8.2 billion in the year 2019. Two of the fastest growing sectors of the market, electrophysiology and ablation devices, will be driven by a 10% to 20% growth in the number of patients treated for atrial fibrillation.

Medical Device Surgical Procedures

Abbott Enters Electrophysiology Fray With Topera, ACT Deals

The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.

Medical Device

Use The Force: St. Jude Hopes To Build AFib Footprint With Pressure-Sensing Catheter

The TactiCath Quartz irrigated ablation catheter, acquired in the Endosense deal in 2013, lets electrophysiologists monitor the force exerted by the catheter tip on the endocardium during an atrial fibrillation ablation procedure.

Medtech 2013: Device Companies Go Where The Growth Is

To stave off the sluggish growth in established markets, multinational medtechs not only are finding new business in countries with booming health care industries but they’re also forging new ways to serve customers. Device companies now are pushing into services, such as disease management, and angling to compete more aggressively on pricing.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Nicolas Marsault, CFO
    Laurent Grandidier, VP, Sales & Mktg.
  • Contact Info
  • Endosense SA
    Phone: (41) 22 306 1960
    Chemin du Grand-Puits 42
    Meyrin, CH-1217
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register